AXOGEN INC (AXGN) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AXGN • US05463X1063

35.02 USD
+0.17 (+0.49%)
At close: Feb 2, 2026
35.72 USD
+0.7 (+2%)
After Hours: 2/2/2026, 8:00:01 PM
Fundamental Rating

5

Overall AXGN gets a fundamental rating of 5 out of 10. We evaluated AXGN against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of AXGN get a neutral evaluation. Nothing too spectacular is happening here. AXGN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AXGN had positive earnings in the past year.
  • In the past year AXGN had a positive cash flow from operations.
  • AXGN had negative earnings in each of the past 5 years.
  • AXGN had negative operating cash flow in 4 of the past 5 years.
AXGN Yearly Net Income VS EBIT VS OCF VS FCFAXGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

  • AXGN has a better Return On Assets (-0.97%) than 72.58% of its industry peers.
  • AXGN has a better Return On Equity (-1.74%) than 72.58% of its industry peers.
  • AXGN has a Return On Invested Capital of 1.65%. This is in the better half of the industry: AXGN outperforms 67.20% of its industry peers.
Industry RankSector Rank
ROA -0.97%
ROE -1.74%
ROIC 1.65%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
AXGN Yearly ROA, ROE, ROICAXGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

  • With a decent Operating Margin value of 1.84%, AXGN is doing good in the industry, outperforming 67.20% of the companies in the same industry.
  • AXGN has a better Gross Margin (74.76%) than 84.95% of its industry peers.
  • In the last couple of years the Gross Margin of AXGN has remained more or less at the same level.
Industry RankSector Rank
OM 1.84%
PM (TTM) N/A
GM 74.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
AXGN Yearly Profit, Operating, Gross MarginsAXGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXGN is destroying value.
  • The number of shares outstanding for AXGN has been increased compared to 1 year ago.
  • AXGN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, AXGN has an improved debt to assets ratio.
AXGN Yearly Shares OutstandingAXGN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AXGN Yearly Total Debt VS Total AssetsAXGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • AXGN has an Altman-Z score of 9.77. This indicates that AXGN is financially healthy and has little risk of bankruptcy at the moment.
  • AXGN's Altman-Z score of 9.77 is amongst the best of the industry. AXGN outperforms 88.71% of its industry peers.
  • The Debt to FCF ratio of AXGN is 23.40, which is on the high side as it means it would take AXGN, 23.40 years of fcf income to pay off all of its debts.
  • AXGN has a better Debt to FCF ratio (23.40) than 68.82% of its industry peers.
  • A Debt/Equity ratio of 0.40 indicates that AXGN is not too dependend on debt financing.
  • The Debt to Equity ratio of AXGN (0.40) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 23.4
Altman-Z 9.77
ROIC/WACC0.16
WACC10.36%
AXGN Yearly LT Debt VS Equity VS FCFAXGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • AXGN has a Current Ratio of 4.09. This indicates that AXGN is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of AXGN (4.09) is better than 69.35% of its industry peers.
  • A Quick Ratio of 2.64 indicates that AXGN has no problem at all paying its short term obligations.
  • AXGN has a Quick ratio of 2.64. This is in the better half of the industry: AXGN outperforms 62.37% of its industry peers.
Industry RankSector Rank
Current Ratio 4.09
Quick Ratio 2.64
AXGN Yearly Current Assets VS Current LiabilitesAXGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

  • AXGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2089670227099910400.00%, which is quite impressive.
  • AXGN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.72%.
  • The Revenue has been growing by 11.92% on average over the past years. This is quite good.
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 58.75% on average over the next years. This is a very strong growth
  • AXGN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.07% yearly.
EPS Next Y128.66%
EPS Next 2Y95.22%
EPS Next 3Y82.13%
EPS Next 5Y58.75%
Revenue Next Year20.03%
Revenue Next 2Y17.84%
Revenue Next 3Y17.63%
Revenue Next 5Y17.07%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AXGN Yearly Revenue VS EstimatesAXGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
AXGN Yearly EPS VS EstimatesAXGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 120.76, the valuation of AXGN can be described as expensive.
  • Based on the Price/Earnings ratio, AXGN is valued a bit cheaper than 66.13% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.41, AXGN is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 70.69, the valuation of AXGN can be described as expensive.
  • 66.67% of the companies in the same industry are more expensive than AXGN, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.64, AXGN is valued quite expensively.
Industry RankSector Rank
PE 120.76
Fwd PE 70.69
AXGN Price Earnings VS Forward Price EarningsAXGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • 63.44% of the companies in the same industry are more expensive than AXGN, based on the Enterprise Value to EBITDA ratio.
  • 66.67% of the companies in the same industry are more expensive than AXGN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 784.04
EV/EBITDA 161.56
AXGN Per share dataAXGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • AXGN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as AXGN's earnings are expected to grow with 82.13% in the coming years.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y95.22%
EPS Next 3Y82.13%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for AXGN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

AXOGEN INC

NASDAQ:AXGN (2/2/2026, 8:00:01 PM)

After market: 35.72 +0.7 (+2%)

35.02

+0.17 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)02-23
Inst Owners91.28%
Inst Owner Change0.9%
Ins Owners1.59%
Ins Owner Change0.28%
Market Cap1.62B
Revenue(TTM)214.71M
Net Income(TTM)-2.10M
Analysts83.75
Price Target37.03 (5.74%)
Short Float %6.14%
Short Ratio3.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)74.96%
Min EPS beat(2)64.15%
Max EPS beat(2)85.77%
EPS beat(4)3
Avg EPS beat(4)10.46%
Min EPS beat(4)-222.55%
Max EPS beat(4)114.46%
EPS beat(8)7
Avg EPS beat(8)179.5%
EPS beat(12)11
Avg EPS beat(12)144.63%
EPS beat(16)14
Avg EPS beat(16)118.71%
Revenue beat(2)2
Avg Revenue beat(2)4.58%
Min Revenue beat(2)3.69%
Max Revenue beat(2)5.47%
Revenue beat(4)2
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-1.48%
Max Revenue beat(4)5.47%
Revenue beat(8)5
Avg Revenue beat(8)1.84%
Revenue beat(12)7
Avg Revenue beat(12)0.83%
Revenue beat(16)8
Avg Revenue beat(16)0.37%
PT rev (1m)-0.27%
PT rev (3m)45.85%
EPS NQ rev (1m)1.6%
EPS NQ rev (3m)-25.49%
EPS NY rev (1m)0.3%
EPS NY rev (3m)8.61%
Revenue NQ rev (1m)0.9%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.87%
Valuation
Industry RankSector Rank
PE 120.76
Fwd PE 70.69
P/S 7.52
P/FCF 784.04
P/OCF 248.14
P/B 13.37
P/tB 14.12
EV/EBITDA 161.56
EPS(TTM)0.29
EY0.83%
EPS(NY)0.5
Fwd EY1.41%
FCF(TTM)0.04
FCFY0.13%
OCF(TTM)0.14
OCFY0.4%
SpS4.66
BVpS2.62
TBVpS2.48
PEG (NY)0.94
PEG (5Y)N/A
Graham Number4.13
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -1.74%
ROCE 2.09%
ROIC 1.65%
ROICexc 2.04%
ROICexgc 2.13%
OM 1.84%
PM (TTM) N/A
GM 74.76%
FCFM 0.96%
ROA(3y)-10.24%
ROA(5y)-11.1%
ROE(3y)-20.3%
ROE(5y)-20.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.5%
F-Score6
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 23.4
Debt/EBITDA 4.82
Cap/Depr 73.42%
Cap/Sales 2.07%
Interest Coverage 0.59
Cash Conversion 65.09%
Profit Quality N/A
Current Ratio 4.09
Quick Ratio 2.64
Altman-Z 9.77
F-Score6
WACC10.36%
ROIC/WACC0.16
Cap/Depr(3y)361.61%
Cap/Depr(5y)683.78%
Cap/Sales(3y)9.04%
Cap/Sales(5y)13.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2089670227099910400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y128.66%
EPS Next 2Y95.22%
EPS Next 3Y82.13%
EPS Next 5Y58.75%
Revenue 1Y (TTM)18.72%
Revenue growth 3Y13.72%
Revenue growth 5Y11.92%
Sales Q2Q%23.51%
Revenue Next Year20.03%
Revenue Next 2Y17.84%
Revenue Next 3Y17.63%
Revenue Next 5Y17.07%
EBIT growth 1Y146.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1601.87%
EBIT Next 3Y219.09%
EBIT Next 5Y118.11%
FCF growth 1Y108.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y256.84%
OCF growth 3YN/A
OCF growth 5YN/A

AXOGEN INC / AXGN FAQ

What is the fundamental rating for AXGN stock?

ChartMill assigns a fundamental rating of 5 / 10 to AXGN.


What is the valuation status for AXGN stock?

ChartMill assigns a valuation rating of 4 / 10 to AXOGEN INC (AXGN). This can be considered as Fairly Valued.


What is the profitability of AXGN stock?

AXOGEN INC (AXGN) has a profitability rating of 4 / 10.


How financially healthy is AXOGEN INC?

The financial health rating of AXOGEN INC (AXGN) is 6 / 10.


What is the expected EPS growth for AXOGEN INC (AXGN) stock?

The Earnings per Share (EPS) of AXOGEN INC (AXGN) is expected to grow by 128.66% in the next year.